NeurAxis, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
NRXS NYSE American 3841 neuraxis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NeurAxis, Inc.

NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage - Nov 15th, 2024 4:46 pm
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues - Nov 12th, 2024 1:10 pm
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024 - Nov 5th, 2024 2:00 pm
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market - Nov 4th, 2024 2:00 pm
NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024 - Oct 29th, 2024 1:00 pm
NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - Oct 22nd, 2024 1:00 pm
Zacks Initiates Coverage of NeurAxis With Neutral Recommendation - Sep 25th, 2024 2:49 pm
The Zacks Analyst Blog Highlights Costco Wholesale, Alibaba, GE Aerospace, Applied Energetics and NeurAxis - Sep 25th, 2024 1:41 pm
Top Analyst Reports for Costco Wholesale, Alibaba & GE Aerospace - Sep 24th, 2024 8:30 pm
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - Sep 19th, 2024 1:00 pm
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 - Aug 27th, 2024 1:00 pm
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 - Aug 13th, 2024 1:00 pm
NeurAxis Reports Second Quarter 2024 Financial Results - Aug 9th, 2024 12:00 pm
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024 - Aug 5th, 2024 1:00 pm
NeurAxis Submits Application to FDA to Expand IB-Stim Label - Jun 7th, 2024 3:41 pm
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure - Jun 7th, 2024 1:00 pm
NeurAxis Reports First Quarter 2024 Financial Results - May 22nd, 2024 12:00 pm
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - May 21st, 2024 1:00 pm
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida - May 16th, 2024 1:00 pm
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024 - May 15th, 2024 8:30 pm